Agomab Therapeutics NV (AGMB) Debt Ratio (2025 - 2026)
Agomab Therapeutics (AGMB) posted Debt Ratio of 0.02 for Q2 2026, down 45.46% on a QoQ basis from 0.04 in Q4 2025.
Analysis
Agomab Therapeutics NV (AGMB) Debt Ratio (2025 - 2026) Analysis & Trends
Agomab Therapeutics has reported Debt Ratio for 2 years, with the latest figure at 0.02 in Q2 2026.
- On a quarterly basis, Debt Ratio changed N/A year-over-year to 0.02 in Q2 2026; TTM through Jun 2026 was 0.02, a N/A change from a year earlier, with the FY2025 full-year figure at 0.04, changed N/A from the prior year.
- Debt Ratio was 0.02 for Q2 2026 at Agomab Therapeutics, down from 0.04 in the prior quarter.
- The five-year high for Debt Ratio was 0.04 in Q4 2025, with the low at 0.02 in Q2 2026.
Peer Set
Peer Comparison
API Access
Agomab Therapeutics NV Debt Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=debt-ratio&ticker=AGMB&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "debt-ratio", "ticker": "AGMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=debt-ratio&ticker=AGMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();